Oxford Nanopore Technologies (LON:ONT – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported GBX (4.90) EPS for the quarter, Digital Look Earnings reports. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.
Oxford Nanopore Technologies Stock Performance
ONT stock opened at GBX 133.90 on Wednesday. The stock’s 50 day simple moving average is GBX 118.16 and its 200 day simple moving average is GBX 122.69. The company has a current ratio of 3.56, a quick ratio of 6.01 and a debt-to-equity ratio of 8.96. Oxford Nanopore Technologies has a 12-month low of GBX 95.61 and a 12-month high of GBX 215.60. The stock has a market capitalization of £1.31 billion, a PE ratio of -8.87 and a beta of 0.91.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on ONT. Peel Hunt reissued a “hold” rating and set a GBX 153 price target on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th. Berenberg Bank decreased their target price on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating for the company in a research note on Wednesday. Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a report on Monday, July 20th. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of GBX 200.75.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Articles
- Five stocks we like better than Oxford Nanopore Technologies
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
